1. Reinforcing the Bridges and Scaling up
EU/USCooperation on Patient Summary
Trillium II
This project has received funding from the
European Union’s Horizon 2020 research
and innovation programme under grant
agreement No 727745

3. • P
• S
It emphasizes the need to provide generic solutions
for global application beyond a particular region or
country.
Health record extract comprising a standardized collection of
clinical and contextual information (retrospective, concurrent,
prospective) that provides a snapshot in time of a subject of
care’s health information and healthcare
SOURCE: ISO/TR 12773-1:2009 (en) Business requirements for health summary records — Part 1: Requirements]
 International

4. Vision
• “In order to further the care for citizens across the
globe, we agree to collaborate on a single,
common International Patient Summary (IPS)
specification that is readily usable by all clinicians
for the (cross-border) unscheduled care of a
patient.”
Scope
• “The IPS specification shall focus on a minimal and
non-exhaustive Patient Summary, which is
specialty-agnostic and condition-independent,
but still clinically relevant.”
IPSPrinciples

5. eHN EU PS
Guidelines
CEN/EN 17269
IPS
CEN/TS 17288
IPS
HL7 IPS CDA IGHL7 IPS FHIR IG
refer refer
implement
Provide guidance for EU
refine

6. eHN EU PS
Guidelines
CEN/EN 17269
IPS
CEN/TS 17288
IPS
HL7 IPS CDA IGHL7 IPS FHIR IG
refer refer
implement implement
Provide guidance for EU
refine
EU standard Global
aspiration
EU scope
Global Standards

7. •prEN 17269 ballot passed
•prTS 17288 ballot

8. • HL7 CDA IPS IG (STU) Published
• HL7 FHIR IPS IG (STU)
• Expected publication with FHIR R4 (begin 2019).

9. • The HL7 and CEN collaboration on IPS has worked superbly well with
4 specifications near completion in just 2 years !
• Hopefully, to be extended..

10. Towards a
FHIR IPS
“library”
Extending the scope
of patient summaries
beyond
emergency/unplanned
Refine the IPS
components, with the
knowledge gained
from the project.

11. Implementable
Applicable for global use
Extensible and open
Sustainable
Minimal
Non-exhaustive
Specialty-agnostic
Condition-independent
..but still clinically relevant
DataSet
Principles

13. The IPS is a document !
as a document
Current Intended Use Expected Future Use
as a document and a as a library

14. Library of
reusable..
(fragments; resources;
building blocks;…)
Common “core” set of data
With minimal common terminologies
Extensible
extensions

15. IPSs and Mobile Field Hospital
Encounter Reports were build on (HL7
FHIR) IPS resources

17. Trillium II Core Set (1st version)

18. Date of
Immunization
VaccineType

19. Attribute WHO ICVP Trillium II DataSet Implementation Notes
Vaccine or prophylaxis X Vaccine Code
Date of vaccination X Vaccination Date
Manufacturer of vaccine or prophylaxis X Manufacturer
batch no. of vaccine or prophylaxis X Lot Number
brand name of the product Trade Name
Commercial Product identifier Covered by the IPS profile
Product expiring date To be added in the data set.
Covered (Immunization.expirationDate)
Target site + laterality Administration Site
route of administration Administration Route
not administered flag Not Given
reason for not administering Reason Not Given
Disease targeted X Target Diseases
Certificate validity from to (coverage) X VaccinationValidity Current implementation specify only year
Administration progressive number Planned Doses
Next booster (date) X Immunization include protocol data, but not the plan.
ImmunizationRecommendation is used for future plans.
Instructions to Patient X FixedText for ICVP; to be added
Information for Physicians X FixedText for ICVP; to be added
Administering centre X Performer
Administering professional X Performer

20. Trillium II + extension for
supporting theVaccination
Validity
vaccineCode

21. More is available from the
Immunization resource